Zobrazeno 1 - 10
of 14
pro vyhledávání: '"D. V. Shcheblyakov"'
Autor:
T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 3, Pp 294-311 (2024)
INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these
Externí odkaz:
https://doaj.org/article/42d3d9ef80914aaeb81eba3135e5b8a7
Autor:
D. S. Polyansky, E. I. Ryabova, A. A. Derkaev, N. S. Starkov, I. S. Kashapova, D. V. Shcheblyakov, A. P. Karpov, I. B. Esmagambetov
Publikováno v:
Тонкие химические технологии, Vol 19, Iss 3, Pp 240-257 (2024)
Objectives. To develop an effective technology for the cultivation of Chinese hamster ovary (CHO) cells stably producing GamP2C5 antibody which is a component I of the GamCoviMab candidate drug for emergency prevention and therapy of infection caused
Externí odkaz:
https://doaj.org/article/f7728fe6b8d24b39a617b008c5aafefc
Autor:
D. S. Polyansky, E. I. Ryabova, A. A. Derkaev, N. S. Starkov, I. S. Kashapova, D. V. Shcheblyakov, A. P. Karpov, I. B. Esmagambetov
Publikováno v:
Тонкие химические технологии, Vol 19, Iss 4, Pp 384-385 (2024)
Externí odkaz:
https://doaj.org/article/aec01be7d1d74faab305952348de0be3
Autor:
A. A. Derkaev, E. I. Ryabova, V. V. Prokofiev, I. A. Favorskaya, D. M. Grousova, I. B. Esmagambetov, I. V. Dolzhikova, D. V. Shcheblyakov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 1, Pp 76-89 (2023)
Monitoring of the proportion of immune individuals and the effectiveness of vaccination in a population involves evaluation of several important parameters, including the level of virus-neutralising antibodies. In order to combat the COVID-19 pandemi
Externí odkaz:
https://doaj.org/article/c2ef79d862e848b580cfcb9a4600ef94
Autor:
E. I. Ryabova, A. A. Derkaev, I. B. Esmagambetov, D. V. Shcheblyakov, M. A. Dovgiy, D. V. Byrikhina, V. V. Prokofiev, I. P. Chemodanova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 4, Pp 266-278 (2021)
Adeno-associated virus vectors are among the most promising ones for the delivery of transgenes to various organs and tissues. Recombinant adeno-associated virus (rAAV) is able to transduce both dividing and non-dividing cells, has low immunogenicity
Externí odkaz:
https://doaj.org/article/a5592cc67a714f74b4dcfdab539478b7
Autor:
O. D. Popova, O. V. Zubkova, T. A. Ozharovskaia, D. I. Zrelkin, D. V. Voronina, I. V. Dolzhikova, D. V. Shcheblyakov, B. S. Naroditsky, D. Yu. Logunov, A. L. Gintsburg
Publikováno v:
Вопросы вирусологии, Vol 66, Iss 2, Pp 91-102 (2021)
The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1]. Although expansion of Lassa fever caused by thi
Externí odkaz:
https://doaj.org/article/8712d4df58614c4692a44a0e8aff11f6
Publikováno v:
Вопросы вирусологии, Vol 63, Iss 6, Pp 245-249 (2018)
Some drugs candidates for treatment of Ebola virus disease (EVD), have been studied, monoclonal antibody (mAb) cocktails have shown great potential as EVD therapeutics. The advantages of mAb therapy include low toxicity, high specificity and versatil
Externí odkaz:
https://doaj.org/article/edee77fce65641e78691a63cbc8b588f
Autor:
I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatulin, A. S. Dzharullaeva, N. M. Tukhvatulina, D. V. Shcheblyakov, M. M. Shmarov, E. A. Tokarskaya, Y. V. Simakova, D. A. Egorova, D. N. Scherbinin, I. L. Tutykhina, A. A. Lysenko, A. V. Kostarnoy, P. G. Gancheva, T. A. Ozharovskaya, B. V. Belugin, L. V. Kolobukhina, V. B. Pantyukhov, S. I. Syromyatnikova, I. V. Shatokhina, T. V. Sizikova, I. G. Rumyantseva, A. F. Andrus, N. V. Boyarskaya, A. N. Voytyuk, V. F. Babira, S. V. Volchikhina, D. A. Kutaev, A. N. Bel'skih, K. V. Zhdanov, S. M. Zakharenko, S. V. Borisevich, D. Y. Logunov, B. S. Naroditsky, A. L. Gintsburg
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 613-620 (2017)
Ebola hemorrhagic fever, also known as Ebola virus disease or EVD, is one of the most dangerous viral diseases in humans and animals. In this open-label, dose-escalation clinical trial, we assessed the safety, side effects, and immunogenicity of a no
Externí odkaz:
https://doaj.org/article/847acaea0f3742c5b47c8188f24da836
Autor:
I V, Dolzhikova, E A, Tokarskaya, A S, Dzharullaeva, A I, Tukhvatulin, D V, Shcheblyakov, O L, Voronina, S I, Syromyatnikova, S V, Borisevich, V B, Pantyukhov, V F, Babira, L V, Kolobukhina, B S, Naroditsky, D Y, Logunov, A L, Gintsburg
Publikováno v:
Acta Naturae
The Ebola virus disease (EVD) is one of the most dangerous infections affecting humans and animals. The first EVD outbreaks occurred in 1976 in Sudan and Zaire. Since then, more than 20 outbreaks have occurred; the largest of which (2014−2016) evol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00e4314f0dda11d519bb249fd7e96970
https://pubmed.ncbi.nlm.nih.gov/29104771
https://pubmed.ncbi.nlm.nih.gov/29104771
Autor:
D. V. Shcheblyakov, A. L. Ginzburg, I. V. Rakovskaya, Denis Y. Logunov, Boris S. Naroditsky, M M Shmarov
Publikováno v:
Acta Naturae
Toll-like receptors are the essential components of innate immunity. It is shown that TLRs play an essential role in the immune resistance of an organism to bacterial and viral infections. The binding of TLR to its own ligands results in the activati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9afc9f4304ac718f27cdae75e0e2d9c
http://europepmc.org/articles/PMC3347616
http://europepmc.org/articles/PMC3347616